查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2023482

定序耗材市場分析及預測（至2035年）：依類型、產品類型、服務、技術、組件、應用、材料類型、製程及最終用戶分類

Sequencing Consumables Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, Process, End User
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球定序耗材市場預計將從2025年的94億美元成長到2035年的653億美元，複合年成長率（CAGR）為17.8%。每年數百萬次的定序定序都使用Illumina等公司提供的耗材，顯示市場需求旺盛。這些耗材包括試劑、試劑盒和流動池等次世代定序所必需的組件。根據處理能力和應用領域，每次運行的價格通常在500美元到1500美元之間。由於每次定序都需要新的耗材，因此耗材銷售仍是企業持續的收入來源。隨著成本的不斷降低，耗材的普及程度不斷提高，加上定序技術在診斷、研究和個人化醫療領域的應用日益廣泛，這些因素持續推動市場銷售和收入的成長。

定序耗材市場的應用細分領域主要由臨床診斷主導，這得益於定序技術在識別基因突變和支持精準醫療方面的廣泛應用。隨著癌症和遺傳疾病發生率的上升，對準確、早期診斷的需求顯著成長，而定序在其中發揮著至關重要的作用。伴隨診斷和非侵入性產前檢測 (NIPT) 等應用正在迅速發展，從而實現標靶治療和疾病早期檢測。次世代定序(NGS) 技術的不斷進步進一步提升了效率、準確性和可及性，從而推動了該細分領域的成長。

市場區隔
種類 試劑、試劑盒、酵素、緩衝液、磁珠、培養板、試管及其他物品。
產品 DNA定序耗材、RNA定序耗材、蛋白質定序耗材等。
服務 定序服務、生物資訊服務及其他
科技 次世代定序（NGS）、桑格定序、單分子即時（SMRT）定序、奈米孔定序等。
成分 耗材、設備、軟體及其他
目的 臨床診斷、藥物發現、農業與動物研究、法醫學、環境檢測等。
材料類型 塑膠、玻璃、矽膠及其他
過程 樣品製備、定序、數據分析及其他相關任務。
最終用戶 學術和研究機構、製藥和生物技術公司、醫院和診所、受託研究機構等。

終端使用者群體主要由學術和研究機構主導，它們廣泛利用定序耗材進行基因組研究、生物標記發現和大規模人群研究。這些機構得到了政府不斷成長的資金支持以及旨在推進基因組研究的全球性舉措的支持。製藥和生物技術公司也佔了相當大的市場佔有率，它們利用定序進行藥物研發、臨床試驗和個人化治療方法的開發。加強產學合作正加速創新，拓展定序技術的應用範圍，並進一步提升定序耗材在推動醫療保健與生命科學領域發展的重要性。

區域概覽

北美憑藉其強大的基因組研究生態系統、高昂的醫療保健支出以及對次世代定序(NGS) 技術的早期應用，在全球定序耗材市場佔最大佔有率。美國在腫瘤學、罕見疾病診斷、感染疾病追蹤和精準醫療等領域廣泛應用定序技術，引領該地區的發展。領先的生物技術公司、學術研究機構和大規模基因組舉措顯著推動了對試劑、樣品製備盒和流動池等耗材的需求。政府機構和私人投資者的大力資助進一步加速了基因組研究活動，使北美成為全球定序耗材市場的主要產生收入來源。

亞太地區定序耗材市場預計將實現最高的複合年成長率，這主要得益於基因組研究的快速發展、醫療領域投資的增加以及精準醫療的日益普及。中國、印度、日本和韓國等國家正大力投資大規模基因測序計畫和國家生物樣本庫建設。遺傳性疾病和感染疾病的日益普及也推動了對先進定序技術的需求。生物技術產業的擴張、學術研究合作的加強以及定序成本的下降進一步促進了市場成長。政府主導的基因組計畫以及新一代定序（NGS）技術在臨床上的廣泛應用，鞏固了亞太地區作為全球成長最快區域市場的地位。

主要趨勢和促進因素

基因組研究的快速進展和精準醫療的普及

基因組研究的快速發展和精準醫療方法的日益普及是定序耗材市場的主要促進因素。次世代定序技術被廣泛用於識別基因變異、診斷罕見疾病和開發標靶治療。腫瘤學和慢性病領域對個人化治療策略的需求不斷成長，顯著推高了試劑、試劑盒和樣本製備材料等定序耗材的消耗量。此外，大規模基因組圖譜計畫和生物技術研究投入的增加也加速了市場成長。定序平台技術的不斷進步進一步提高了定序的準確性和處理能力，從而推動了全球對定序耗材的整體需求。

擴大臨床基因組學和人群規模定序計劃

定序耗材市場的主要機會在於臨床基因體學和大規模人群定序計畫的擴展。各國政府和醫療機構正加大對國家基因組學舉措的投入，以改善疾病預測、預防和個人化治療。隨著定序技術融入常規臨床診斷，其應用範圍正從研究領域擴展到主流醫學。此外，定序成本的下降正在加速新興經濟體對定序技術的採用。感染疾病監測、癌症基因組學和藥物基因體學的發展進一步推動了市場需求。隨著生技公司、醫院和研究機構之間合作的日益密切，全球定序耗材市場預計將顯著成長。

目錄

第1章摘要整理

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 試劑
    • 成套工具
    • 酵素
    • 緩衝溶液
    • 珠
    • 盤子
    • 管子
    • 其他
  • 市場規模及預測：依產品分類
    • DNA定序耗材
    • RNA定序耗材
    • 蛋白質定序耗材
    • 其他
  • 市場規模及預測：依技術分類
    • 次世代定序（NGS）
    • 桑格定序
    • 單分子即時（SMRT）定序
    • 奈米孔定序
    • 其他
  • 市場規模及預測：依應用領域分類
    • 臨床診斷
    • 藥物發現
    • 農業和畜牧業調查
    • 法醫學
    • 環境測試
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 學術研究機構
    • 製藥和生物技術公司
    • 醫院和診所
    • 合約研究機構
    • 其他
  • 市場規模及預測：依製程分類
    • 樣品製備
    • 定序
    • 數據分析
    • 其他
  • 市場規模及預測：依組件分類
    • 消耗品
    • 裝置
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 定序服務
    • 生物資訊服務
    • 其他
  • 市場規模及預測：依材料類型分類
    • 塑膠
    • 玻璃
    • 矽
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Illumina
  • Thermo Fisher Scientific
  • Agilent Technologies
  • Qiagen
  • Bio-Rad Laboratories
  • Roche Diagnostics
  • PerkinElmer
  • Pacific Biosciences
  • Oxford Nanopore Technologies
  • Becton Dickinson
  • Takara Bio
  • Fluidigm
  • 10x Genomics
  • Promega Corporation
  • New England Biolabs
  • LGC Biosearch Technologies
  • Integrated DNA Technologies
  • Zymo Research
  • Eurofins Scientific
  • BGI Genomics

第9章 關於我們

簡介目錄
Product Code: GIS34512

The global Sequencing Consumables Market is projected to grow from $9.4 billion in 2025 to $65.3 billion by 2035, at a compound annual growth rate (CAGR) of 17.8%. Demand is high, with millions of sequencing runs conducted annually using consumables supplied by companies like Illumina Inc.. These include reagents, kits, and flow cells essential for next-generation sequencing. Pricing typically ranges from USD 500 to USD 1,500 per run depending on throughput and application. Consumables represent a recurring revenue stream, as each sequencing process requires new materials. Cost reductions over time have improved accessibility, while increasing adoption in diagnostics, research, and personalized medicine continues to drive both volume and revenue growth.

The Application segment in the sequencing consumables market is primarily dominated by clinical diagnostics, driven by the increasing use of sequencing technologies to identify genetic mutations and support precision medicine. The rising prevalence of cancer and genetic disorders has significantly increased the demand for accurate and early diagnosis, where sequencing plays a critical role. Applications such as companion diagnostics and non-invasive prenatal testing (NIPT) are expanding rapidly, enabling targeted therapies and early-stage disease detection. Continuous advancements in next-generation sequencing (NGS) technologies are further enhancing efficiency, accuracy, and accessibility, thereby strengthening growth in this segment.

Market Segmentation
TypeReagents, Kits, Enzymes, Buffers, Beads, Plates, Tubes, Others
ProductDNA Sequencing Consumables, RNA Sequencing Consumables, Protein Sequencing Consumables, Others
ServicesSequencing Services, Bioinformatics Services, Others
TechnologyNext-Generation Sequencing (NGS), Sanger Sequencing, Single-Molecule Real-Time (SMRT) Sequencing, Nanopore Sequencing, Others
ComponentConsumables, Instruments, Software, Others
ApplicationClinical Diagnostics, Drug Discovery, Agricultural and Animal Research, Forensic Science, Environmental Testing, Others
Material TypePlastic, Glass, Silicon, Others
ProcessLibrary Preparation, Sequencing, Data Analysis, Others
End UserAcademic and Research Institutes, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Contract Research Organizations, Others

The End User segment is led by academic and research institutions, which extensively use sequencing consumables for genomic research, biomarker discovery, and large-scale population studies. These institutions are supported by increasing government funding and global initiatives focused on advancing genomics research. Pharmaceutical and biotechnology companies also represent a major share, utilizing sequencing for drug discovery, clinical trials, and development of personalized therapies. Growing collaborations between academia and industry players are accelerating innovation and expanding applications of sequencing technologies, reinforcing the importance of consumables in driving advancements in healthcare and life sciences.

Geographical Overview

North America holds the largest market share in the Sequencing Consumables Market due to its strong genomics research ecosystem, high healthcare spending, and early adoption of next-generation sequencing (NGS) technologies. The United States dominates the region with extensive use of sequencing in oncology, rare disease diagnostics, infectious disease tracking, and precision medicine programs. Leading biotechnology firms, academic research institutions, and large-scale genomic initiatives significantly drive consumables demand such as reagents, library preparation kits, and flow cells. Strong funding from government agencies and private investors further accelerates genomic research activities, making North America the primary revenue-generating region in the global sequencing consumables landscape.

Asia Pacific is expected to register the highest CAGR in the Sequencing Consumables Market due to rapid expansion of genomics research, increasing healthcare investments, and growing adoption of precision medicine. Countries such as China, India, Japan, and South Korea are investing heavily in large-scale genomic sequencing programs and national bio-banking initiatives. Rising prevalence of genetic disorders and infectious diseases is also driving demand for advanced sequencing technologies. Expanding biotechnology industries, increasing academic research collaborations, and declining sequencing costs further support market growth. Government-backed genomics projects and increasing clinical integration of NGS technologies position Asia Pacific as the fastest-growing regional market globally.

Key Trends and Drivers

Rapid growth in genomic research and precision medicine adoption

A key driver of the Sequencing Consumables Market is the rapid expansion of genomic research and the increasing adoption of precision medicine approaches. Next-generation sequencing technologies are widely used for identifying genetic variations, diagnosing rare diseases, and developing targeted therapies. The growing demand for personalized treatment strategies in oncology and chronic diseases is significantly increasing the consumption of sequencing consumables such as reagents, kits, and sample preparation materials. Additionally, large-scale genome mapping projects and rising investment in biotechnology research are accelerating market growth. Continuous technological advancements in sequencing platforms further enhance accuracy, throughput, and overall demand for consumables globally.

Expansion of clinical genomics and population-scale sequencing programs

A major opportunity in the Sequencing Consumables Market lies in the expansion of clinical genomics and large-scale population sequencing programs. Governments and healthcare organizations are increasingly investing in national genome initiatives to improve disease prediction, prevention, and personalized treatment. Integration of sequencing into routine clinical diagnostics is expanding applications beyond research into mainstream healthcare. Additionally, declining costs of sequencing are enabling broader adoption in emerging economies. Growth in infectious disease surveillance, cancer genomics, and pharmacogenomics further strengthens demand. Increasing partnerships between biotech companies, hospitals, and research institutes are expected to significantly expand the market for sequencing consumables globally.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Technology
  • 2.4 Key Market Highlights by Application
  • 2.5 Key Market Highlights by End User
  • 2.6 Key Market Highlights by Process
  • 2.7 Key Market Highlights by Component
  • 2.8 Key Market Highlights by Services
  • 2.9 Key Market Highlights by Material Type

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Reagents
    • 4.1.2 Kits
    • 4.1.3 Enzymes
    • 4.1.4 Buffers
    • 4.1.5 Beads
    • 4.1.6 Plates
    • 4.1.7 Tubes
    • 4.1.8 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 DNA Sequencing Consumables
    • 4.2.2 RNA Sequencing Consumables
    • 4.2.3 Protein Sequencing Consumables
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Technology (2020-2035)
    • 4.3.1 Next-Generation Sequencing (NGS)
    • 4.3.2 Sanger Sequencing
    • 4.3.3 Single-Molecule Real-Time (SMRT) Sequencing
    • 4.3.4 Nanopore Sequencing
    • 4.3.5 Others
  • 4.4 Market Size & Forecast by Application (2020-2035)
    • 4.4.1 Clinical Diagnostics
    • 4.4.2 Drug Discovery
    • 4.4.3 Agricultural and Animal Research
    • 4.4.4 Forensic Science
    • 4.4.5 Environmental Testing
    • 4.4.6 Others
  • 4.5 Market Size & Forecast by End User (2020-2035)
    • 4.5.1 Academic and Research Institutes
    • 4.5.2 Pharmaceutical and Biotechnology Companies
    • 4.5.3 Hospitals and Clinics
    • 4.5.4 Contract Research Organizations
    • 4.5.5 Others
  • 4.6 Market Size & Forecast by Process (2020-2035)
    • 4.6.1 Library Preparation
    • 4.6.2 Sequencing
    • 4.6.3 Data Analysis
    • 4.6.4 Others
  • 4.7 Market Size & Forecast by Component (2020-2035)
    • 4.7.1 Consumables
    • 4.7.2 Instruments
    • 4.7.3 Software
    • 4.7.4 Others
  • 4.8 Market Size & Forecast by Services (2020-2035)
    • 4.8.1 Sequencing Services
    • 4.8.2 Bioinformatics Services
    • 4.8.3 Others
  • 4.9 Market Size & Forecast by Material Type (2020-2035)
    • 4.9.1 Plastic
    • 4.9.2 Glass
    • 4.9.3 Silicon
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Technology
      • 5.2.1.4 Application
      • 5.2.1.5 End User
      • 5.2.1.6 Process
      • 5.2.1.7 Component
      • 5.2.1.8 Services
      • 5.2.1.9 Material Type
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Technology
      • 5.2.2.4 Application
      • 5.2.2.5 End User
      • 5.2.2.6 Process
      • 5.2.2.7 Component
      • 5.2.2.8 Services
      • 5.2.2.9 Material Type
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Technology
      • 5.2.3.4 Application
      • 5.2.3.5 End User
      • 5.2.3.6 Process
      • 5.2.3.7 Component
      • 5.2.3.8 Services
      • 5.2.3.9 Material Type
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Technology
      • 5.3.1.4 Application
      • 5.3.1.5 End User
      • 5.3.1.6 Process
      • 5.3.1.7 Component
      • 5.3.1.8 Services
      • 5.3.1.9 Material Type
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Technology
      • 5.3.2.4 Application
      • 5.3.2.5 End User
      • 5.3.2.6 Process
      • 5.3.2.7 Component
      • 5.3.2.8 Services
      • 5.3.2.9 Material Type
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Technology
      • 5.3.3.4 Application
      • 5.3.3.5 End User
      • 5.3.3.6 Process
      • 5.3.3.7 Component
      • 5.3.3.8 Services
      • 5.3.3.9 Material Type
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Technology
      • 5.4.1.4 Application
      • 5.4.1.5 End User
      • 5.4.1.6 Process
      • 5.4.1.7 Component
      • 5.4.1.8 Services
      • 5.4.1.9 Material Type
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Technology
      • 5.4.2.4 Application
      • 5.4.2.5 End User
      • 5.4.2.6 Process
      • 5.4.2.7 Component
      • 5.4.2.8 Services
      • 5.4.2.9 Material Type
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Technology
      • 5.4.3.4 Application
      • 5.4.3.5 End User
      • 5.4.3.6 Process
      • 5.4.3.7 Component
      • 5.4.3.8 Services
      • 5.4.3.9 Material Type
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Technology
      • 5.4.4.4 Application
      • 5.4.4.5 End User
      • 5.4.4.6 Process
      • 5.4.4.7 Component
      • 5.4.4.8 Services
      • 5.4.4.9 Material Type
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Technology
      • 5.4.5.4 Application
      • 5.4.5.5 End User
      • 5.4.5.6 Process
      • 5.4.5.7 Component
      • 5.4.5.8 Services
      • 5.4.5.9 Material Type
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Technology
      • 5.4.6.4 Application
      • 5.4.6.5 End User
      • 5.4.6.6 Process
      • 5.4.6.7 Component
      • 5.4.6.8 Services
      • 5.4.6.9 Material Type
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Technology
      • 5.4.7.4 Application
      • 5.4.7.5 End User
      • 5.4.7.6 Process
      • 5.4.7.7 Component
      • 5.4.7.8 Services
      • 5.4.7.9 Material Type
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Technology
      • 5.5.1.4 Application
      • 5.5.1.5 End User
      • 5.5.1.6 Process
      • 5.5.1.7 Component
      • 5.5.1.8 Services
      • 5.5.1.9 Material Type
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Technology
      • 5.5.2.4 Application
      • 5.5.2.5 End User
      • 5.5.2.6 Process
      • 5.5.2.7 Component
      • 5.5.2.8 Services
      • 5.5.2.9 Material Type
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Technology
      • 5.5.3.4 Application
      • 5.5.3.5 End User
      • 5.5.3.6 Process
      • 5.5.3.7 Component
      • 5.5.3.8 Services
      • 5.5.3.9 Material Type
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Technology
      • 5.5.4.4 Application
      • 5.5.4.5 End User
      • 5.5.4.6 Process
      • 5.5.4.7 Component
      • 5.5.4.8 Services
      • 5.5.4.9 Material Type
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Technology
      • 5.5.5.4 Application
      • 5.5.5.5 End User
      • 5.5.5.6 Process
      • 5.5.5.7 Component
      • 5.5.5.8 Services
      • 5.5.5.9 Material Type
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Technology
      • 5.5.6.4 Application
      • 5.5.6.5 End User
      • 5.5.6.6 Process
      • 5.5.6.7 Component
      • 5.5.6.8 Services
      • 5.5.6.9 Material Type
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Technology
      • 5.6.1.4 Application
      • 5.6.1.5 End User
      • 5.6.1.6 Process
      • 5.6.1.7 Component
      • 5.6.1.8 Services
      • 5.6.1.9 Material Type
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Technology
      • 5.6.2.4 Application
      • 5.6.2.5 End User
      • 5.6.2.6 Process
      • 5.6.2.7 Component
      • 5.6.2.8 Services
      • 5.6.2.9 Material Type
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Technology
      • 5.6.3.4 Application
      • 5.6.3.5 End User
      • 5.6.3.6 Process
      • 5.6.3.7 Component
      • 5.6.3.8 Services
      • 5.6.3.9 Material Type
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Technology
      • 5.6.4.4 Application
      • 5.6.4.5 End User
      • 5.6.4.6 Process
      • 5.6.4.7 Component
      • 5.6.4.8 Services
      • 5.6.4.9 Material Type
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Technology
      • 5.6.5.4 Application
      • 5.6.5.5 End User
      • 5.6.5.6 Process
      • 5.6.5.7 Component
      • 5.6.5.8 Services
      • 5.6.5.9 Material Type

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Illumina
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Thermo Fisher Scientific
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Agilent Technologies
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Qiagen
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Bio-Rad Laboratories
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Roche Diagnostics
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 PerkinElmer
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Pacific Biosciences
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Oxford Nanopore Technologies
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Becton Dickinson
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Takara Bio
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Fluidigm
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 10x Genomics
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Promega Corporation
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 New England Biolabs
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 LGC Biosearch Technologies
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Integrated DNA Technologies
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Zymo Research
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Eurofins Scientific
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 BGI Genomics
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us